ResearcherRGCC International GmbHActive in the last 2 years
Ioannis Papasotiriou
Matched on ORCID iD 0000-0002-6145-946X; OpenAlex author ID A5057888085.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 0, last author 2)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 2
2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 2
- Second-line therapy adjustment for advanced pancreatic cancer using circulating tumor cells: Preliminary results. Last author DOI 10.1016/j.ctarc.2025.100956↗
- Anvirzel™ in combination with cisplatin in breast, colon, lung, prostate, melanoma and pancreatic cancer cell lines. Last author DOI 10.1186/2050-6511-14-18↗
Closest collaborators
The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Panagiotis Apostolou · 2 shared papers, 2013–2025
- Paper Second-line therapy adjustment for advanced pancreatic cancer using circulating tumor cells: Preliminary results. DOI 10.1016/j.ctarc.2025.100956↗
- Paper Anvirzel™ in combination with cisplatin in breast, colon, lung, prostate, melanoma and pancreatic cancer cell lines. DOI 10.1186/2050-6511-14-18↗
- Joachim Drevs · 1 shared paper, 2025
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.